All News about Roivant Sciences Ltd![]() ![]() ![]() Via Benzinga
![]() Via Benzinga
![]() ![]() ![]()
Where Roivant Sciences Stands With Analysts
March 25, 2024
Via Benzinga
![]()
The Analyst Landscape: 4 Takes On Roivant Sciences
February 14, 2024
Via Benzinga
![]() ![]() ![]() ![]() ![]()
Roivant Sciences Earnings Preview
February 12, 2024
Via Benzinga
![]()
Assessing Roivant Sciences: Insights From 5 Financial Analysts
January 02, 2024
Via Benzinga
![]() ![]() Via Benzinga
![]() ![]() ![]()
10 Health Care Stocks Whale Activity In Today's Session
March 29, 2024
Via Benzinga
![]() ![]()
5 Value Stocks In The Healthcare Sector
February 19, 2024
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]()
Roivant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ Disease
December 20, 2023
From Roivant Sciences
Via GlobeNewswire
![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|